IN DEPTH Can gene therapies for haemophilia defend their high price tags? Trial termination analysis unveils a silver lining for patient recruitment New dawn for the EU's joint procurement crisis response Regulatory What Rishi Sunak can do for the UK pharma industry Amidst a swap in leadership, the pharmaceutical industry hopes Rishi Sunak will free up funding and boost the economy Big Data Inside the European mass shift to data-driven health solutions Market Access Drug shortages signal difficult outlook for cardiovascular care Can gene therapies for haemophilia defend their high price tags? Trial termination analysis unveils a silver lining for patient recruitment New dawn for the EU's joint procurement crisis response 11/23/2022 21:46:50
Can gene therapies for haemophilia defend their high price tags?
Trial termination analysis unveils a silver lining for patient recruitment
New dawn for the EU's joint procurement crisis response